Global Amebiasis Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Amebiasis Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica. Symptoms of this disease include loose stool, abdominal cramping, and stomach pain.
Amebiasis report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Amebiasis market is projected to reach US$ 1323.9 million in 2033, increasing from US$ 875 million in 2022, with the CAGR of 6.1% during the period of 2023 to 2033. Demand from Hospital and Pharmacy are the major drivers for the industry.
The amebiasis drugs market is driven by the high burden of amebiasis infections, caused by the parasite Entamoeba histolytica, especially in developing regions with poor sanitation and healthcare facilities. Amebiasis can lead to severe gastrointestinal symptoms and potentially life-threatening complications. The increasing prevalence and severity of the disease have contributed to the demand for effective drugs to treat and manage amebiasis. Additionally, advancements in medical research and drug development have led to the introduction of new and improved therapies for better patient outcomes. However, challenges include the need for early diagnosis and proper management to prevent complications, potential drug resistance, and limited access to healthcare in some regions. Overcoming these challenges through increased awareness, affordable treatment options, and improved healthcare infrastructure will be crucial for the sustained growth of the amebiasis drugs market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Amebiasis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Dr. Reddy’s Laboratories
Mission Pharmacal
Aceto Corporation
Mylan Pharmaceuticals
Impax Laboratories
Pfizer
Sanofi
Lupin Pharmaceuticals
Glenmark Pharmaceuticals
Sun Pharmaceutical
Heritage Pharmaceuticals
Segment by Type
Metronidazole
Paromomycin
Tinidazole
Other
Hospital
Pharmacy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Amebiasis market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Amebiasis introduction, etc. Amebiasis Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Amebiasis market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Amebiasis report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Amebiasis market is projected to reach US$ 1323.9 million in 2033, increasing from US$ 875 million in 2022, with the CAGR of 6.1% during the period of 2023 to 2033. Demand from Hospital and Pharmacy are the major drivers for the industry.
The amebiasis drugs market is driven by the high burden of amebiasis infections, caused by the parasite Entamoeba histolytica, especially in developing regions with poor sanitation and healthcare facilities. Amebiasis can lead to severe gastrointestinal symptoms and potentially life-threatening complications. The increasing prevalence and severity of the disease have contributed to the demand for effective drugs to treat and manage amebiasis. Additionally, advancements in medical research and drug development have led to the introduction of new and improved therapies for better patient outcomes. However, challenges include the need for early diagnosis and proper management to prevent complications, potential drug resistance, and limited access to healthcare in some regions. Overcoming these challenges through increased awareness, affordable treatment options, and improved healthcare infrastructure will be crucial for the sustained growth of the amebiasis drugs market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Amebiasis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Dr. Reddy’s Laboratories
Mission Pharmacal
Aceto Corporation
Mylan Pharmaceuticals
Impax Laboratories
Pfizer
Sanofi
Lupin Pharmaceuticals
Glenmark Pharmaceuticals
Sun Pharmaceutical
Heritage Pharmaceuticals
Segment by Type
Metronidazole
Paromomycin
Tinidazole
Other
Segment by Application
Hospital
Pharmacy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Amebiasis market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Amebiasis introduction, etc. Amebiasis Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Amebiasis market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices